US 12,473,295 B2
Substituted straight chain spiro derivatives
Wei Cai, Shanghai (CN); Xuedong Dai, Shanghai (CN); Olivier Alexis Georges Querolle, Issy-les Moulineaux (FR); Johannes Wilhelmus John F. Thuring, Antwerp (BE); Yingtao Liu, Shanghai (CN); Lianzhu Liu, Shanghai (CN); Yanping Xu, Noblesville, IN (US); Liqiang Fu, Shanghai (CN); Ming Li, Shanghai (CN); Lichao Fang, Shanghai (CN); Xiangjun Deng, Shanghai (CN); Qiwu Zhao, Shanghai (CN); Kangying Li, Tianjin (CN); Alicia Tee Fuay Ng, Shanghai (CN); Nicolas Freddy J. Darville, Linkhout (BE); Edward Cleator, Cambridgeshire (GB); Gregor Thomas Urbanietz, Boom (BE); William Marc Maton, Mol (BE); and Vineet Pande, Vosselaar (BE)
Assigned to Janssen Pharmaceutica NV, Beerse (BE)
Appl. No. 17/604,818
Filed by Janssen Pharmaceutica NV, Beerse (BE)
PCT Filed Dec. 17, 2020, PCT No. PCT/CN2020/137266
§ 371(c)(1), (2) Date Oct. 19, 2021,
PCT Pub. No. WO2021/121327, PCT Pub. Date Jun. 24, 2021.
Claims priority of provisional application 62/961,775, filed on Jan. 16, 2020.
Claims priority of application No. PCT/CN2019/126760 (WO), filed on Dec. 19, 2019; and application No. PCT/CN2020/126595 (WO), filed on Nov. 4, 2020.
Prior Publication US 2023/0142285 A1, May 11, 2023
Int. Cl. C07D 487/10 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); C07D 207/08 (2006.01); C07D 403/04 (2006.01)
CPC C07D 487/10 (2013.01) [A61P 35/00 (2018.01); A61P 35/02 (2018.01); C07D 207/08 (2013.01); C07D 403/04 (2013.01)] 20 Claims
 
1. A compound wherein the compound is

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt or a solvate thereof.